COMBINED TREATMENT OF PELVIC EXENTERATIVE SURGERY AND INTRAOPERATIVE PELVIC HYPERTHERMOCHEMOTHERAPY FOR LOCALLY ADVANCED RECTOSIGMOID CANCER - REPORT OF A CASE

A huge rectosigmoidal cancer which extended into the urinary bladder in a 64-year-old man is herein described. The tumor occupied the pelvic and lower abdominal cavities, while the rectosigmoid was totally obstructed. No hepatic or pulmonary metastasis was evident. The ventral and bank sides of the peritoneum in the right lower abdomen, right common iliac vessels, bilateral ureters, terminal ileum, cecum, ascending colon, and urinary bladder were all directly invaded by the tumor, but the aorta, sacrum, and lower rectum were free of cancer. Consequently, an anterior pelvic exenteration was carried out along with an heal conduit and a right hemicolectomy. Immediately after the exenteration, intra-pelvic hyperthermochemotherapy was performed using a 46-47 degrees C perfusate containing 40 mu g/ml of mitomycin C (MMC) and 200 mu g/ml of cisplatin (CDDP), for 90 min, in an attempt to prevent any further local recurrence. A right hemicolectomy and a permanent colostomy were done simultaneously with the hyperthermia treatment. After an uneventful postoperative course, the patient was prescribed adjuvant chemotherapy, i.e., two administrations of 17 mg/m(2) and 21mg/m(2) of MMC, and ten doses of 710 mg/m(2) of 5-fluorouracil (5-FU) followed by five doses of 535 mg/m(2) of 5-FU. At the time of this writing, the patient is still alive without recurrence at 21 months after surgery.